Analyses showed that compared with their counterparts in the placebo group, patients in the ALC group were more likely to have had an improvement of at least one grade in their neuropathy, both at 8 weeks (51% vs
Clinical trials show continued loss is possible with higher doses or compound switches, often reaching 1522% total body weight reduction
Keeping up with drug safety and efficacy information can assist providers in making responsible decisions about their patients' health and well-being
Quick Answer: A bad taste in the mouth with GLP-1 medications is an uncommon side effect, typically related to delayed gastric emptying and gastrointestinal effects, and often improves within 4 to 8 weeks
While mild, transient burning at the injection site is generally benign, certain signs and symptoms warrant prompt medical evaluation
Disclaimer: This information is for educational purposes only and does not substitute professional medical advice